Found: 13
Select item for more details and to access through your institution.
Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells.
- Published in:
- Prostate, 2001, v. 48, n. 4, p. 254, doi. 10.1002/pros.1105
- By:
- Publication type:
- Article
Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 278, doi. 10.1186/1476-4598-9-278
- By:
- Publication type:
- Article
Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 13, p. 1006, doi. 10.1093/jnci/djh184
- By:
- Publication type:
- Article
Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 408, doi. 10.3390/cancers11030408
- By:
- Publication type:
- Article
Pre-clinical and clinical significance of heparanase in Ewing's sarcoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2011, v. 15, n. 9, p. 1857, doi. 10.1111/j.1582-4934.2010.01190.x
- By:
- Publication type:
- Article
A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes.
- Published in:
- International Journal of Cancer, 2001, v. 92, n. 5, p. 738, doi. 10.1002/1097-0215(20010601)92:5<738::AID-IJC1249>3.0.CO;2-2
- By:
- Publication type:
- Article
Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative.
- Published in:
- International Journal of Cancer, 2000, v. 85, n. 3, p. 384, doi. 10.1002/(SICI)1097-0215(20000201)85:3<384::AID-IJC15>3.0.CO;2-Y
- By:
- Publication type:
- Article
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.
- Published in:
- Molecules, 2018, v. 23, n. 11, p. 2915, doi. 10.3390/molecules23112915
- By:
- Publication type:
- Article
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.965261
- By:
- Publication type:
- Article
Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02150-y
- By:
- Publication type:
- Article
Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets.
- Published in:
- 2020
- By:
- Publication type:
- Editorial